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T. Tang,1 J.R. Boyle,1 A.K. Dixon2 and K. Varty1*1Regional Vascular Unit, and 2Department of Radiology, Addenbrooke’s NHS Trust, University of Cambridge,
Cambridge, UKBackground. Inflammatory abdominal aortic aneurysms (IAAA) are a variant of aortic aneurysm characterised by
extensive peri-aneurysmal fibrosis, thickened walls and dense adhesions and represent between 3 and 10% of all abdominal
aortic aneurysms (AAA). Surgery is technically challenging and is still associated with an increased morbidity and
mortality. Controversy exists about aetiology and pathogenesis.
Methods. We review the literature on the current theories, the available imaging modalities and the current thinking on
management of IAAA. A Medline database search was performed. Articles were cross-referenced.
Results and conclusions. Aneurysm development is multifactorial with important genetic and environmental factors. The
literature supports the theory that IAAA arise from the same antigenic stimulus that is responsible for the non-IAAA,
representing one extreme of an inflammatory spectrum. The results after open repair have improved and there is now little
difference in the mortality between non-IAAA and IAAA repair. However, there is likely to be a role for endovascular
stenting in IAAA management and this requires further study. It is clear that closer follow-up of patients after IAAA repair
with either technique is necessary to monitor the inflammatory process.
No evidence-based follow-up protocol exists but three to six-monthly monitoring of renal function and erythrocyte
sedimentation rate (ESR) for 24 months post-repair would seem a reasonable regime.Keywords: Inflammation; Aortic aneurysm; Abdominal.Introduction
The inflammatory abdominal aortic aneurysm (IAAA)
remains a challenge to the vascular surgeon because it
is associated with an increased surgical risk to the
patient.1 Recent research into aneurysm biology high-
lights the role of inflammation within the wall but has
yet to explain the peri-aneurysmal fibrosis occurring
in inflammatory aneurysms. The aim of this study is to
review the current understanding of this relatively
uncommon subtype of aortic aneurysm and to
characterise the aetiology and pathogenesis of this
disease. We wish to highlight the areas of controversy
and new developments in the diagnostic imaging and
treatment of this problem.ing author. Mr Kevin Varty, MD FRCS, Consultant
rgeon, Regional Vascular Unit, Box 201, Level 7,
’s Hospital, Hills Road, Cambridge CB2 2QQ, UK.
: kevin.varty@addenbrookes.nhs.uk
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Medline and Pubmed literature searches using MeSH
terms ‘inflammation’, ‘aortic aneurysm’ and ‘aortic
aneurysm, abdominal’, identified papers and studies
for this review. Keywords such as pathogenesis,
aetiology, CT scan, ultrasound, endovascular and
repair were used to refine the search. Articles were
obtained and evaluated by the authors of this manu-
script. Inclusion criteria in this reviewwere dependent
on the relevance to the subject of IAAA and not to
aneurysmal disease alone.Definition
Walker first described the inflammatory aneurysm in
1972 to characterise a group of 19 patients whose
aneurysms showed a ‘thick, firm, smooth wall with
a shiny white appearance’ and where the ‘dense
fibrosis extended to involve adjacent structures’.2Eur J Vasc Endovasc Surg 29, 353–362 (2005)
doi:10.1016/j.ejvs.2004.12.009, available online at http://www.sciencedirect.com onved.
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now defined by the presence of a thickened aneurysm
wall, marked peri-aneurysmal and retroperitoneal
fibrosis and dense adhesions of adjacent abdominal
organs.1,3,4Incidence
IAAAs represent 3–10% of all abdominal aortic
aneurysms and have a predilection to occur in
males.1–10 Depending on the series, the male to female
ratio varies from 30:1 to 6:1.1,3,8,11 Mean age of
occurrence ranges from 62 to 68 years. It is interesting
to note that the age of occurrence is 5–10 years younger
than the mean age of patients with atherosclerotic
aneurysms.12 The co-incidence of patients who
develop IAAA and who smoke is high. This ranges
from 77%1 to 100% of patients.4,10 Nitecki recently
showed that a significantly higher proportion of
patients with IAAA were current smokers compared
to patients with non-inflammatory aneurysms.9
There is evidence for the role of genetic factors in
the development of IAAA.3,9 A higher percentage of
patients with IAAAs had a positive family history of
aneurysms (17%) when compared with patients with
non-inflammatory aneurysms (1.7%) and clinical
experience suggests clustering of these aneurysms in
northern Europeans.9 Furthermore, as discussed ear-
lier aneurysms are more predisposed to occur in
males.3,4,9,12 Rasmussen’s group showed that a genetic
risk determinant could be mapped to the HLA-DR B1
locus in IAAA patients.13 Haug’s group has shown
that IAAA is associated with an increased incidence of
autoimmune disease.14 However, further research is
necessary to explore whether IAAA might be a
separate entity with a role of antigen binding in the
origin of the disease.PresentationSymptomatology
The presentation of IAAA has been previously well
documented and characterised.9 The triad of abdomi-
nal or back pain, weight loss and an elevated
erythrocyte sedimentation rate (ESR) in a patient
with an AAA is highly suggestive of one with an
inflammatory component. Very few patients with
IAAA are asymptomatic according to Walker’s orig-
inal description.2 In fact 80% of patients with IAAA
have symptoms of back, flank or abdominal pain.4,10Eur J Vasc Endovasc Surg Vol 29, April 2005This is significantly higher compared to patients with
non-IAAA. Only 10–20% of these patients are sympto-
matic.9 However, how the significance of pain in IAAA
compared with non-IAAA was calculated is not
mentioned. Significant amount of weight loss and
anorexia have been reported in up to 40% of patients
with an IAAA.6,9Signs
Fifteen to 30% patients present with a tender pulsatile
abdominal mass.6,7 A patient now and then presents
with anuria as the first symptom of an IAAA but this is
rare.15 The most frequent abnormal blood test is a
raised erythrocyte sedimentation rate (ESR) represent-
ing an increase in the inflammatory response. This was
described in Walker’s original paper2 and confirmed
in subsequent reports. A raised ESR is found in 40–
88% of IAAA patients, which is a significantly greater
proportion of patients compared to those with non-
IAAA.2,5,8,9 The findings of a raised temperature and
white cell count seem to be more variable and in fact
some have found these parameters to be normal in
patients with IAAA.10 C-reactive protein (CRP), an
acute phase reactant has been found to be significantly
elevated in patients who present with symptoms or
rupture of an AAA.16 Although, this was not found in
asymptomatic AAA patients, it has not been found to
be consistently elevated specifically in an IAAA.PathophysiologyInflammation
A greater understanding of the pathology and to a
lesser extent the aetiology of AAAs has been estab-
lished in recent years. Aneurysm development is
multifactorial in nature, with both a genetic predis-
position and environmental factors acting together to
initiate a cascade of arterial degradation. An important
part of aneurysm development is the ubiquitous
inflammatory cell infiltrate, which has been demon-
strated in all abdominal aortic aneurysms.17 Although
this inflammation is more pronounced in
‘Inflammatory AAAs’ current understanding favours
one pathological process with varying degrees of
inflammation18 rather than the distinct clinical entity
first proposed by Walker.2 A contemporary study has
corroborated this theory by demonstrating identical
HLA alleles functioning in both inflammatory and
degenerative AAAs, supporting the concept of a
common immune-mediated pathogenesis.13
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matory cells in contrast to AAA tissue extract which
demonstrate gross inflammatory changes.17,19 Koch
et al. demonstrated that aortic inflammation existed
as a progressive continuum from relatively non-
inflammatory to inflammatory AAAs.17 Various
authors have characterized the inflammatory cell
infiltrate, which consists of macrophages, T-lympho-
cytes and B-lymphocytes, which are predominately
found in the adventitia and to a lesser extent the
media of the aorta.17,19,20 There also appears to be
an imbalance in the ratio of T-helper cells to
T-suppressor cells, with the predominance of the
former stimulating macrophages and causing acti-
vation and proliferation of B-lymphocytes. Macro-
phages may also act as antigen presenting cells and
thus perpetuate the immune response.17 The antigen
that initiates and further propagates the inflamma-
tory response is yet to be fully elucidated. Recent
interest has focused on the elastin derived peptides
(EDPs), breakdown products of the medial elastin as
a possible candidate.21 This theory hypothesizes that
an initial insult causes elastin degradation and the
resultant EDPs stimulates the inflammatory
response within the aortic wall. Recent evidence
has confirmed that EDPs-attract monocytes and
interact with the elastin binding protein on the
monocyte cell surface.22 Once present within the
aortic wall white cells contribute to aneurysm
genesis by direct degradation of the extracellular
matrix (ECM) by releasing various proteolytic
enzymes particularly metalloproteinases and also
through cytokine production. This magnifies the
inflammatory response further and also stimulates
endothelial and smooth muscle cells within the
aortic wall to contribute to ECM destruction.23 This
greater understanding of the pathophysiology has
stimulated interest in targeted pharmacotherapy
aimed at both reducing inflammation24 and inhibit-
ing metalloproteinase25,26 activity to reduce aneu-
rysm growth.
It has long been recognized that steroid treatment of
inflammatory aortic aneurysms can lead to regression
of the inflammation if not a reduction in aneurysm
size.27 More recent work has demonstrated predniso-
lone, cyclosporin and CD-18 monoclonal antibodies
inhibit aneurysmal change in rat models.28,29 Con-
temporary experimental work has also demonstrated
that the cyclo-oxygenase-2 inhibitor, indomethacin
reduces the production of prostaglandin E2 and the
pro-inflammatory cytokines IL-1beta and IL-6 in
aneurysm explants.24 These studies further underline
the importance of inflammation in aneurysm
development.Infection
Some authors have hypothesized that inflammation
within the aortic wall may be a response to infection.
Both herpes simplex virus and cytomegalovirus have
been identified more frequently in AAA wall than in
normal aorta. Furthermore, both viruses are more
prevalent in inflammatory AAAs.30,31
More recent interest has focused on Chlamydia
pneumonia as a possible causative agent. Chlamydia
and its associated antigens are more prevalent in
aneurysmal than normal aortic tissue.32,33 In addition,
higher anti-Chlamydia antibody titres are associated
with increased expansion.34 A contemporary study
has demonstrated aortic expansion in a rabbit model
after exposure to both live Chlamydia organisms and
chlamydial membrane antigens.35 Furthermore, the
anti-inflammatory and/or antibiotic actions of the
macrolide group of drugs have been demonstrated to
reduce aortic expansion in this animal model and also
AAA growth in a randomised controlled study.36
Whether inflammatory aneurysms are associated with
higher levels of Chlamydia and its antigens in
comparison with degenerative AAAs is yet to be
determined. The variable inflammatory process within
the wall of AAAs is consistent with infection.36 This
infection theory is based on work with non-IAAA. No
such correlation has been yet described in IAAA.RadiologyRole of ultrasound
Ultrasound is widely available, non-invasive and
readily diagnoses abdominal aortic aneurysms
(AAA). Indeed, in some communities, the aneurysm
may be detected by screening with ultrasound.
Recognition of a cuff of soft tissue around the calcified
margin of the aneurysm may prompt the sonographer
to question the possibility of an inflammatory com-
ponent. So too may dilatation of the renal collecting
systems and proximal ureters, especially if there is no
obvious pelvic cause for the obstruction.
It must be remembered that the accuracy of
ultrasound is very dependent on the experience of
the operator and the body habitus of the patient.
Therefore, the differentiation between a cuff of
inflammatory material in an inflammatory aneurysm
(periaortitis) and extensive para-aortic lymphadeno-
pathy in lymphoma can be difficult.
Ultrasound is much easier in thin patients. The
ultrasound beam becomes attenuated by fat. LowerEur J Vasc Endovasc Surg Vol 29, April 2005
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posterior abdominal diameter is excessive. Both
factors reduce conspicuity of retroperitoneal struc-
tures. So too does excessive intra-abdominal gas. This
last factor is very important in the acute setting, when
swallowed air in dilated loops of bowel affected by
ileus may completely obscure the retroperitoneum.
Thus, the unexpected finding of an inflammatory
component to the aneurysm during emergency sur-
gery is not unusual.Role of computed tomography
Computed tomography (CT) has become the mainstay
of assessing inflammatory abdominal aortic aneur-
ysms (Fig. 1). Ever since the original descriptions of the
use of CT in determining the longitudinal extent of
aneurysms,37 increasing technological advances have
allowed more understanding of the natural history of
aneurysms and can provide extremely valuable
information, which aids therapeutic decisions. CT
was the first non-invasive technique that could
reliably demonstrate the cuff of inflammatory material
around the aorta. Information from CT provided
further credence to the pathologist’s concept, which
unified the diagnoses of retroperitoneal fibrosis and
inflammatory aneurysm into the single entity
periaortitis.38
In periaortitis, CT shows a cuff of soft tissue around
the aorta (of whatever calibre, Fig. 2). This enhances
with intravenous iodinated contrast media. It can
usually be differentiated form lymphoma around an
aneurysm though one can occasionally be caught out
by sheet like tumour infiltration rather than more
obvious nodal enlargement. Certain tumours have the
propensity to evoke a strong inflammatory fibrous
reaction, which can cause problems of interpretation
(bladder tumour and liposarcoma are two notable
culprits). It is said that the aorta remains closer to the
vertebrae in periaortitis than in tumour infiltration39
but, when the aorta is ectatic and deformed by an
aneurysm, this feature is less helpful.
Haemorrhage is another potential diagnostic pitfall.
When an aneurysm has ruptured, the tissue planes
within the retroperitoneum become poorly defined,
which can make the identification of an inflammatory
component difficult. However, blood usually tracks
into the para-renal fat well away from the aneurysm,
except at the very point of rupture.40 Furthermore,
fresh blood in the retroperitoneum usually appears of
higher CT attenuation than adjacent muscle; the soft
tissue of an inflammatory aneurysm will have similarEur J Vasc Endovasc Surg Vol 29, April 2005CT appearance to muscle before enhancement with
intravenous contrast medium.
Another potentially interpretative pitfall around an
aneurysm is the displaced third part of duodenum: in
most centres abdominal CT is performed following
preparation of the small bowel with contrast medium;
in the acute situation (e.g. aneurysm rupture), this may
not occur. The third part of duodenum can be
intimately applied to the neck of the aneurysm and,
because the air within the lumen has been ‘squeezed’
out, it may be mistaken for a rind of haemorrhage or
inflammation.
The relatively recent introduction of multidetector
CT has made the diagnosis and the evaluation of the
extent of an inflammatory aneurysm even easier and
the pitfalls described above may cause less trouble. On
a 16-detector system the individual slices can be
around 1 mm thick, which means that the individual
pixels on the image represent a voxel (volume
element) within the patient, which is approximately
isometric. The multiplanar reconstructions of AAAs
allow full appreciation of the lumen, the wall, the
extent of any inflammatory material and the position
and degree of distension of the all-important adjacent
ureters.
CT and ultrasound have nearly replaced intrave-
nous urography, which, for the clinical indication of
inflammatory aneurysm, is of historical interest only.
Just occasionally IVU used to be able to provide the
diagnosis of an aneurysmal aorta (by virtue of
calcification in the expanded wall) and suggest the
diagnosis of an inflammatory component (by demon-
strating ureteric obstruction at an appropriate level). A
lot used to be made about the position of the ureters on
the IVU: although medial displacement of the ureters
is a common feature of periaortitis, there is wide
normal variation with body habitus and it was never a
very discriminating feature.
Despite the fact that a formal IVU is rarely
performed, demonstration of the ureters is of key
importance. Delayed CT images may be needed to
show these to optimal effect. On anatomical grounds it
is useful to remember that the ureteric obstruction in
an inflammatory aneurysm usually first affects the left
ureter at about the L4 level. The inferior vena cava
protects the right ureter in the early stages of the
process; obstruction by the inflammatory processmore
often occurs around an inflammatory right common
iliac artery.
Although CT can give some indication about the
degree of and duration of obstruction (dilatation of the
pelvicalyceal system, renal parenchymal atrophy, etc.),
formal evaluation of renal function is best assessed by
nuclear medicine. This may be necessary before
Fig. 1. Computed tomography: a series of axial CT images showing an inflammatory aneurysm involving the origin of the
renal arteries. (a) At the level of the origin of the SMA; the aorta is of normal calibre but has become displaced from the
vertebra by the large aneurysm more inferiorly; the right kidney is hydronephrotic. Note also pancreatic calcification
consistent with chronic pancreatitis. (b) At the level of the left renal artery origin. A large aneurysm with an eccentric lumen.
Note the cuff of soft tissue to the left of the calcification in the wall of the aneurysm. (c) At the level of the left renal vein; the
aneurysm is slightly smaller here; left kidney normal; still a cuff of inflammatory tissue to the left of the aorta. (d) At the level
of the aortic bifurcation. Note how the right ureter is grossly dilated but still protected from the aneurysm by the distorted
inferior vena cava. There is a sizeable anterior inflammatory cuff. On this delayed image the left ureter is of normal calibre
and it opacified promptly. However, it is perilously close to the left margin of the inflammatory process. No opacification of
the right ureter. (e) At the bifurcation: the right ureter is engulfed by inflammatory material around the right common iliac
artery. The left ureter is still of normal calibre and surrounded by normal retroperitoneal fat.
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Fig. 2. Computed tomography: periaortitis around a relatively normal sized aorta. (a) Axial image at the level of the aortic
bifurcation. The lumen of the aorta is well opacified by intravenous contrast medium. There is only minor atheroma and
mural calcification at this anatomical level. The cuff of soft tissue surrounding the aorta is nearly circumferential. The inferior
vena cava (not yet opacified) is distorted by the process and the normal calibre ureter lies close to the right aspect of the IVC.
(b) Coronal CT reconstruction showing the atheromatous involvement of the distal aorta and common iliac arteries to better
effect. The cuff of inflammatory tissue is well demonstrated.
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other kidney. There have been occasional reports of
various scintigraphic studies demonstrating avid
uptake of tracer in the periaortic inflammatory
material and this is yet another method by which an
inflammatory aneurysm may come to light.
CT is also an excellent method of providing follow-
up about the extent of the inflammatory material,
which can change very rapidly following minor
intervention41 and steroid therapy. However, MRI
(see below) may be preferred because of radiation
dose.
With regards the overall accuracy of CT in this
condition, the most comprehensive series comes from
Iino and colleagues.42 In a consecutive series of 355
abdominal aortic aneurysms studied by CT, the
diagnosis was suggested pre-operatively in 16. Sur-
gery revealed 18 inflammatory aneurysms. CT had
correctly identified 15/18 cases with one false positive
result (sensitivity 83.3, specificity 99.7, overall accu-
racy 93.7%).42Role of magnetic resonance imaging
Magnetic resonance imaging (MRI) is a remarkable
method of assessing the aorta. Apart from the fact that
it does not use any ionizing radiation, it is also worth
remembering that intravenous Gadolinium-DTPA is
less nephrotoxic than the iodinated contrast agents
used for CT. Thus, MRI is theoretically a safer
technique if contraindications and the problems of
claustrophobia are thought through. Furthermore,
direct imaging in the coronal plane means that much
of the required information is available without theEur J Vasc Endovasc Surg Vol 29, April 2005need for any reconstruction. Standard T1 and T2
weighted images normally provide all the required
information. The cuff of inflammatory material
enhances avidly with intravenous Gadolinium-
DTPA.43
However, a detailed investigation of the aorta only
provides detailed information about the aorta; not
much information about the ureters is available. Of
course a fluid sensitive T2 weighted sequence can
show the ureters extremely well, but that sequence
will not show the aorta so well. Thus, CT is the
preferred investigation to assess the whole range of
tissues affected by an inflammatory aneurysm; CT is
also better at showing the extent of aortic wall
calcification. MRI is best reserved for specific unan-
swered questions or when there is renal failure. A
compromise T1 weighted sequence provides a good
overall assessment of an inflammatory aneurysm and
is ideal for follow up (rather than CT), when trying to
minimise radiation dose. However, the experience
with MR is more limited than with CT—the largest
published series hangs on five cases.43 Thus, the exact
sensitivity and specificity is not yet known. Theoreti-
cally it should not be very different from that provided
by CT.Intravenous urography (IVU)
Intravenous urography (IVU) has long been the ‘gold
standard’ method of assessing the ureters, even
though CT is increasing being used instead. Lessons
from the days when urography and arteriography
were the only methods of assessing inflammatory
aneurysms should not be forgotten. In particular, the
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even when they are severely obstructed.44 Nor are the
ureters always deviated medially; there is, anyway,
wide anatomical variation in the position of normal
ureters. Another point is that patients with relatively
normal ureters can rapidly become anuric in this
condition.45 It is likely that the ureters lose the capacity
for peristalsis and dilatation due to the fibrotic effects.
Conversely, the ureters can rapidly revert to provide
normal function following minimal doses of steroids
or other intervention.41Nuclear medicine
Nuclear medicine techniques can readily delineate the
differential function of the kidneys although care must
be taken when both kidneys are equally obstructed.
There has long been interest in various agents
revealing increased uptake in the inflammatory
processes in the aortic wall and surrounding tissues.
Recent PET studies suggest that this may become a
useful method of monitoring ‘activity’ in the future.46,47Treatment of Inflammatory Abdominal Aortic
AneurysmsNon-operative
A non-operative approach may be considered when
there is extensive fibrosis around an IAAA presenting
a major technical challenge. The true natural history of
IAAA is unknown and it has been argued that the
thickened inflammatory mantle over the anterolateral
aspect of the aneurysmmay reduce the rupture risk. In
the larger series in the literature the number of IAAA’s
presenting with either acute or ‘chronic’ rupture
ranges from 3.3 to 14%.3,4,9,48–50 Using a case–control
analysis Lindblad and colleagues highlight that this is
a lower rupture rate than for non-inflammatory
AAA.49 Steroid therapy has been used to try and
control the inflammatory process with anecdotal
success51,52 but the risk of rupture remains. Indeed
many surgeons hold the view that steroids may
weaken the aortic wall and increase the risk of rupture.
No controlled studies on the role of steroids in
managing IAAA exist.Operative
Despite the technical difficulties associated with IAAA
data from the literature supports an operativeapproach to management whenever possible. Histori-
cal high mortality rates have reduced, as nicely shown
in the three-decade study of Pennell and co-workers.
Here mortality was 12.5% in 1955–64, falling to 4.2% in
1975–84.3 In recent studies from Ireland and Germany
the 30-day mortality was 3.1 and 5%, respectively.48,50
However, the less selected case control study from 11
Swedish centres had a higher elective mortality rate of
9% for IAAA compared to 0% for non-inflammatory
AAA.49 Another study showed that operating time
was longer in the IAAA group, which also had a
higher need for blood transfusion. Hospital stay,
intensive care unit stay and 30-day mortality were
similar in the two groups.14 Overall these data suggest
that IAAA can be repaired with an acceptably low
mortality in selected cases although the mortality may
be slightly higher than in standard AAA repair. The
potential for a raised morbidity rate also exists with
renal failure and sepsis featuring in one study.9 Long-
term survival after IAAA repair is the same as that for
patients after standard aneurysm repair.3
A variety of open approaches have been advocated
to facilitate repair. Adhesiolysis and mobilisation of
peri-aneurysmal structures was initially favoured
despite problems with duodenal, ureteral and venous
damage leading to increased morbidity. Goldstone
and colleagues described a technique with ‘as little
dissection as possible’ in 1978.10 The aortic neck was
approached via the standard transperitoneal route but
from the left side leaving the duodenum on the front
wall. The renal vein was either mobilised or divided to
access the neck. For more difficult cases where fibrosis
at the level of the renal vein is extensive the technique
described by Crawford with aortic control at the
diaphragm can be used.4 The retroperitoneal approach
has been advocated as a superior alternative by
some,53 although if the retroperitoneal fibrosis is
extensive then even this route is difficult. Randomised
studies have failed to confirm the benefit of the
retroperitoneal approach for aortic reconstruction in
general.54 The trans-peritoneal route, therefore,
remains the most popular approach for IAAA at the
infra-renal or juxta-renal level.3,4,9,48–50Ureterolysis
The management of ureters involved in the inflam-
matory process has become increasingly conservative.
At presentation the ureters will be involved in
approximately 25% of cases, with significantly
impaired renal function in 10–15%.55 Early studies
advocated ureterolysis to prevent on-going ureteric
obstruction accepting the morbidity associated withEur J Vasc Endovasc Surg Vol 29, April 2005
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incidence of these complications is very variable but
clearly there is some scope for morbidity with this
additional procedure combined with IAAA repair.
With growing experience of IAAA repair it became
clear that post-operative persistent ureteric obstruc-
tion was uncommon and, therefore, that ureterolysis
was probably unnecessary. Again the experience from
11 centres reported by Lindblad is interesting.49
Management clearly varied between centres such
that of 39 patients with IAAA and ureteric involve-
ment 19 underwent ureterolysis and 20 did not.
Analysing these patients showed that preoperative
and post-operative creatinine levels were equal in the
two groups. Speziale and colleagues followed 14
patients with impaired renal function and IAAA.55
Ureterolysis was avoided in 12 of these, and 11 (91%)
had normal or improved renal function at follow up
after IAAA repair alone. Even the insertion of pre-
operative ureteral stents was questioned in this study.
Often advocated in order to help intra-operative
identification of the ureters, Speziale and colleagues
point out that in aperistaltic ureters involved in dense
fibrosis this can lead to iatrogenic injury.55 For patients
with anuria and renal failure, percutaneous nephrost-
omy to allow recovery of renal function, followed by
delayed IAAA repair is the most common manage-
ment strategy reported.
Recent studies and reviews have highlighted the
variable regression of retroperitoneal fibrosis after
IAAA repair.9,12,48 Complete regression is seen in only
23–53% of cases after long term follow-up. Partial
regression or no change occurs in the remainder. Thus,
IAAA repair halts the progression of retroperitoneal
fibrosis but does not cure it. In a number of the cases
with on-going fibrosis the ureters are involved and
long term this may lead to renal dysfunction.9,48 Long-
term follow up after IAAA repair with monitoring for
hydronephrosis and renal function has, therefore, been
advocated by some.9 Themanagement of deteriorating
renal function with hydronephrosis after IAAA repair
usually involves steroids or other immunosuppressive
regimes combined with ureteric stenting.Endovascular approaches
In view of the technical difficulty of open IAAA repair
and the increased morbidity and mortality endovas-
cular aneurysm repair (EVAR) is an attractive option.
A number of case reports and small series in the
literature show good early results in terms of patient
survival, early morbidity and aneurysm exclusion.57–61
However, the longer-term regression of the peri-Eur J Vasc Endovasc Surg Vol 29, April 2005aneurysmal fibrosis seen in up to 53% of open repairs
occurs infrequently after endovascular repair. In a
series of seven IAAA treated by EVAR, Deleernijder
and colleagues found that after a mean follow up of 29
months complete regression of the fibrosis had not
occurred in any case.57 Partial regression was seen in
three cases, with no change in four cases. The ureters
had been involved in the fibrosis in five of the IAAA’s
and three remained obstructed at 1-year post-opera-
tively. Vallabhaneni and co-workers have suggested
that this failure to resolve the inflammatory response
by EVAR may be a relative contra-indication to this
form of repair.58 In their experience of six IAAA’s
managed by EVAR, there was no regression of the
fibrosis in five cases and progression in one case. In
three cases ureteric involvement necessitated ureteric
stent placement. It appears that EVAR can provoke an
inflammatory response in the wall of non-inflamma-
tory AAA’s. Mild peri-aneurysmal thickening was
seen on CT in 18% of normal AAA’s treated by EVAR
at a median of 18 months follow-up.58 None of these,
however, led to ureteric obstruction. The aetiology of
this wall thickening is unknown. Histological studies
suggest a foreign body reaction takes place in the
aneurysm wall.62 Others have suggested it may be a
reaction to the thrombosis occurring in the aneurysm
sac.58
It appears from the early reports in the literature
that EVAR repair of IAAA’s is beneficial in terms of
early operative mortality and morbidity. However, it
does not appear to help resolve the inflammatory
reaction in the longer term. Progression of the peri-
aneurysmal fibrosis is rare, however, and in patients
with IAAA and no major ureteric involvement, EVAR
may well have a role to play. Follow up in these cases
would need to include screening for hydronephrosis
and renal function. EVAR repair of IAAAwith ureteric
involvement may be less favourable. Post-operative
ureteric stents and immunosuppressive regimes are
likely to be required in this situation to try and
preserve renal function. Further, experience with
EVAR repair for IAAA is required to assess these
longer-term outcomes in more detail.Summary
Aneurysm development is multifactorial with import-
ant genetic and environmental factors. Inflammation
plays a critical role and current understanding favours
one disease process with varying degrees of inflam-
mation, with the ‘inflammatory aneurysm’ represent-
ing one extreme. The exact aetiology is unclear but
inflammation may be a response to an endogenous
Inflammatory Aortic Aneurysms 361antigen such as EDPs or perhaps and exogenous
infective agent such as Chlamydia pneumoniae.
Ultrasound is usually the first investigation to
demonstrate AAA because it is widely available and
non-invasive. Accuracy though is dependent on the
operator’s experience and patient’s body habitus and
differentiation of inflammatory tissue can be difficult.
Computer tomography has become the mainstay of
imaging and staging IAAA. It is also an excellent
method of providing follow-up on the extent of
inflammation. However, magnetic resonance imaging
may be preferred as it avoids ionizing radiation and is
less nephrotoxic.
Operative repair of a large IAAA remains the
treatment of choice, patient co-morbidity permitting.
Although, the mortality and morbidity is raised for
open repair compared to non-inflammatory aneur-
ysms, results have improved, and the difference is now
relatively small. Endovascular stenting may prevent
rupture but may not control the inflammatory process
to the same degree as open repair. However, there is
likely to be a role for stenting in IAAA management
and this requires further study. It is clear that closer
follow up of patients after IAAA repair with either
technique is necessary to monitor the inflammatory
process and renal function. No evidence-based follow
up protocol exists but three to six-monthly monitoring
of renal function and ESR for 24 months post-repair
would seem a reasonable regime.References
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